280 related articles for article (PubMed ID: 23986582)
1. The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model.
Rocha-Pereira J; Jochmans D; Debing Y; Verbeken E; Nascimento MS; Neyts J
J Virol; 2013 Nov; 87(21):11798-805. PubMed ID: 23986582
[TBL] [Abstract][Full Text] [Related]
2. Post-exposure antiviral treatment of norovirus infections effectively protects against diarrhea and reduces virus shedding in the stool in a mortality mouse model.
Rocha-Pereira J; Kolawole AO; Verbeken E; Wobus CE; Neyts J
Antiviral Res; 2016 Aug; 132():76-84. PubMed ID: 27252124
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic treatment with the nucleoside analogue 2'-C-methylcytidine completely prevents transmission of norovirus.
Rocha-Pereira J; Jochmans D; Neyts J
J Antimicrob Chemother; 2015 Jan; 70(1):190-7. PubMed ID: 25228588
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine.
Rocha-Pereira J; Jochmans D; Dallmeier K; Leyssen P; Cunha R; Costa I; Nascimento MS; Neyts J
Biochem Biophys Res Commun; 2012 Nov; 427(4):796-800. PubMed ID: 23063849
[TBL] [Abstract][Full Text] [Related]
5. The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.
Rocha-Pereira J; Nascimento MS; Ma Q; Hilgenfeld R; Neyts J; Jochmans D
Antimicrob Agents Chemother; 2014 Aug; 58(8):4675-81. PubMed ID: 24890597
[TBL] [Abstract][Full Text] [Related]
6. Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant Variants.
Rocha-Pereira J; Van Dycke J; Neyts J
Antimicrob Agents Chemother; 2015 Dec; 60(3):1907-11. PubMed ID: 26711754
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.
Ng YC; Kim YW; Lee JS; Lee SJ; Jung Song M
J Microbiol; 2018 Sep; 56(9):683-689. PubMed ID: 30141161
[TBL] [Abstract][Full Text] [Related]
8. Norovirus: targets and tools in antiviral drug discovery.
Rocha-Pereira J; Neyts J; Jochmans D
Biochem Pharmacol; 2014 Sep; 91(1):1-11. PubMed ID: 24893351
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of nucleoside analogues against norovirus.
Costantini VP; Whitaker T; Barclay L; Lee D; McBrayer TR; Schinazi RF; Vinjé J
Antivir Ther; 2012; 17(6):981-91. PubMed ID: 22910194
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model.
Kolawole AO; Rocha-Pereira J; Elftman MD; Neyts J; Wobus CE
Antiviral Res; 2016 Aug; 132():46-9. PubMed ID: 27210811
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the activity of 2'-C-methylcytidine against dengue virus replication.
Lee JC; Tseng CK; Wu YH; Kaushik-Basu N; Lin CK; Chen WC; Wu HN
Antiviral Res; 2015 Apr; 116():1-9. PubMed ID: 25614455
[TBL] [Abstract][Full Text] [Related]
12. TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
Enosi Tuipulotu D; Netzler NE; Lun JH; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530841
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response.
Perry JW; Ahmed M; Chang KO; Donato NJ; Showalter HD; Wobus CE
PLoS Pathog; 2012; 8(7):e1002783. PubMed ID: 22792064
[TBL] [Abstract][Full Text] [Related]
14. Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors.
Qu L; Vongpunsawad S; Atmar RL; Prasad BV; Estes MK
J Virol; 2014 Sep; 88(18):10312-26. PubMed ID: 25008934
[TBL] [Abstract][Full Text] [Related]
15. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
[TBL] [Abstract][Full Text] [Related]
16. The Adenosine Analogue NITD008 has Potent Antiviral Activity against Human and Animal Caliciviruses.
Enosi Tuipulotu D; Fumian TM; Netzler NE; Mackenzie JM; White PA
Viruses; 2019 May; 11(6):. PubMed ID: 31151251
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic efficacy of orally administered Bacillus poly-γ-glutamic acid, a non-LPS TLR4 ligand, against norovirus infection in mice.
Lee W; Kim M; Lee SH; Jung HG; Oh JW
Sci Rep; 2018 Jun; 8(1):8667. PubMed ID: 29875467
[TBL] [Abstract][Full Text] [Related]
18. Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses.
Gonzalez-Hernandez MJ; Pal A; Gyan KE; Charbonneau ME; Showalter HD; Donato NJ; O'Riordan M; Wobus CE
PLoS One; 2014; 9(4):e94491. PubMed ID: 24722666
[TBL] [Abstract][Full Text] [Related]
19. Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.
Eltahla AA; Lim KL; Eden JS; Kelly AG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2014 Jun; 58(6):3115-23. PubMed ID: 24637690
[TBL] [Abstract][Full Text] [Related]
20. Interferon lambda (IFN-λ) efficiently blocks norovirus transmission in a mouse model.
Rocha-Pereira J; Jacobs S; Noppen S; Verbeken E; Michiels T; Neyts J
Antiviral Res; 2018 Jan; 149():7-15. PubMed ID: 29080649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
